Very pleased to see David Shulkin actively promote next week’s 4DMedical-hosted webinar to his ~20,000 LinkedIn followers (the link takes you to a 4DMedical branded page but obviously wished he had also mentioned us in his post). I expect we’ll be a (main) feature of discussion at this webinar.
Outside of the webinar, this is the strongest sign yet indicating David Shulkin, Rosie and Leroy Torres and 4DMedical are collaborating diligently behind the scenes to try and get commercial arrangements across the line. Can’t wait to see developments in this space which could happen at any time.
- Forums
- ASX - By Stock
- 4DX
- Research
Research, page-1872
-
- There are more pages in this discussion • 1,132 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DX (ASX) to my watchlist
(20min delay)
|
|||||
Last
56.5¢ |
Change
-0.010(1.74%) |
Mkt cap ! $231.9M |
Open | High | Low | Value | Volume |
59.0¢ | 59.0¢ | 55.5¢ | $251.8K | 442.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 73254 | 56.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
58.0¢ | 518 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 73254 | 0.565 |
2 | 29465 | 0.560 |
2 | 4606 | 0.555 |
6 | 347359 | 0.550 |
3 | 29000 | 0.545 |
Price($) | Vol. | No. |
---|---|---|
0.580 | 518 | 1 |
0.585 | 25000 | 3 |
0.590 | 37771 | 4 |
0.595 | 22698 | 2 |
0.600 | 42644 | 3 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
4DX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online